Q: Our vascular physician prescribes exercise to some of his patients who have peripheral artery disease. He wants to provide the exercise program in the office, because he wants to have these patients monitored closely for their response, due to the nature of the disease. Is there a way to get reimbursed for this since it is a therapeutic procedure for these patients?
Q: A patient in the emergency room (ER) recently complained that she could hear the doctor and nurses discussing details of care of the patient in the bed next to hers. I understand that we should avoid disclosures, but the ER is often noisy and chaotic. How should we handle this situation?
Q: We are using a biosimilar for infliximab but it is manufactured by Merck/Samsung rather than Pfizer/Hospira. CMS requires that a manufacturer specific modifier be appended to the HCPCS code. Is there a new one for Merck/Samsung?
